Clinical significance of measuring prostate-specific antigen

Abstract

The incidence of prostate-specific antigen (PSA) monitoring has increased in recent years. However, interpretation of the results is often ambiguous and leads to uncertainty for both the patient and the treating physician. Advantages and disadvantages of measuring PSA and possibilities for improved interpretation using the variable PSA quotient are given.